These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 22136150)
1. Pharmacological interventions for the treatment of smokeless tobacco use. Ebbert JO; Fagerstrom K CNS Drugs; 2012 Jan; 26(1):1-10. PubMed ID: 22136150 [TBL] [Abstract][Full Text] [Related]
2. Smokeless tobacco cessation interventions: A systematic review. Nethan ST; Sinha DN; Chandan K; Mehrotra R Indian J Med Res; 2018 Oct; 148(4):396-410. PubMed ID: 30666002 [TBL] [Abstract][Full Text] [Related]
3. Interventions to increase adherence to medications for tobacco dependence. Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618 [TBL] [Abstract][Full Text] [Related]
4. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. Hays JT; Ebbert JO Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259 [TBL] [Abstract][Full Text] [Related]
9. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial. Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840 [TBL] [Abstract][Full Text] [Related]
10. Interventions for preventing weight gain after smoking cessation. Parsons AC; Shraim M; Inglis J; Aveyard P; Hajek P Cochrane Database Syst Rev; 2009 Jan; (1):CD006219. PubMed ID: 19160269 [TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy? Sims TH; Fiore MC CNS Drugs; 2002; 16(10):653-62. PubMed ID: 12269859 [TBL] [Abstract][Full Text] [Related]
12. Determinants of Quit Attempts and Short-Term Abstinence among Smokeless Tobacco Users in India: Global Adult Tobacco Survey, 2016-17. Gawde NC; Quazi Syed Z Asian Pac J Cancer Prev; 2024 Mar; 25(3):875-883. PubMed ID: 38546070 [TBL] [Abstract][Full Text] [Related]
13. Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials. Nagano T; Katsurada M; Yasuda Y; Kobayashi K; Nishimura Y Ther Adv Respir Dis; 2019; 13():1753466619875925. PubMed ID: 31533544 [TBL] [Abstract][Full Text] [Related]
14. Smokeless tobacco cessation in South Asian communities: a multi-centre prospective cohort study. Croucher R; Shanbhag S; Dahiya M; Kassim S; Csikar J; Ross L Addiction; 2012 Dec; 107 Suppl 2():45-52. PubMed ID: 23121359 [TBL] [Abstract][Full Text] [Related]
15. Varenicline: a first-line treatment option for smoking cessation. Garrison GD; Dugan SE Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents. Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234 [TBL] [Abstract][Full Text] [Related]
17. Quitting Failure and Success With and Without Using Medication: Latent Classes of Abstinence and Adherence to Nicotine Monotherapy, Combination Therapy, and Varenicline. McCarthy DE; Versella MV Nicotine Tob Res; 2019 Oct; 21(11):1488-1495. PubMed ID: 30107419 [TBL] [Abstract][Full Text] [Related]
18. Bupropion SR for the treatment of smokeless tobacco use. Dale LC; Ebbert JO; Glover ED; Croghan IT; Schroeder DR; Severson HH; Hurt RD Drug Alcohol Depend; 2007 Sep; 90(1):56-63. PubMed ID: 17353101 [TBL] [Abstract][Full Text] [Related]